PubMed · 12370069
Refining retinoids with heteroatoms.
Abstract
Retinoids are a group of synthetic compounds designed to refine the numerous biological activities of retinoic acid into pharmaceuticals for several diseases, including cancer. Designs that conformationally-restricted the rotation of the structures resulted in arotinoids that were biologically active, but with increased toxicity. Incorporation of a heteroatom in one cyclic ring of the arotinoid structures drastically reduced the toxicity, while retaining biological activity. Clinical trials of a heteroarotinoid, Tazarotene, confirmed the improved chemotherapeutic ratio (efficacy/toxicity).
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
D M Benbrook. 2002. Refining retinoids with heteroatoms.. https://doi.org/10.2174/1389557023406160
Cite the original work for its findings. Save a collection to share your selection of sources.